Sign in to view content

Extended Q16W Dosing Potential for Faricimab in Neovascular Age-Related Macular Degeneration (nAMD): STAIRWAY Phase 2 Trial

Philip J. Ferrone, MD, FASRS

Video
Published 2019

Phillip J. Ferrone, MD

AMD Neovascular Part I Symposium

Related

Primary Analysis Results of the Phase 3 Archway Trial of the Port Delivery System With Ranibizumab (PDS) for Patients With Neovascular AMD
Peter A. Campochiaro, MD
Annual Meeting Talks
2020
Episode 24: Acute Retinal Angiographic Changes with Intravitreal Injections with Dr. Richard Rosen
Keyvan Koushan, MD, FRCSC
Member Podcasts
2019
Prospective Trial Comparing Ranibizumab Monthly to Treat and Extent With and Without Angiography-Guided Laser for DME
John F. Payne, MD
Updates from the Field
2016

Category: AMD-Neovascular

See more